Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial

被引：0
作者：
Maria J. G. T. Vehreschild
Petar Atanasov
Kateryna Yurko
Cristian Oancea
Georgi Popov
Valentina Smesnoi
Gheorghe Placinta
Hella Kohlhof
Daniel Vitt
Evelyn Peelen
Jelena Mihajlović
Andreas R. Muehler
机构：
[1] Goethe University Frankfurt,Department of Internal Medicine, Infectious Diseases, Medizinische Klinik II, University Hospital Frankfurt
[2] UMHATEM “N.I.Pirogov” EAD,Clinic of Internal Diseases
[3] Kharkiv National Medical University,Infectious Diseases
[4] University of Medicine and Pharmacy “Victor Babeş” Timişoara,Clinic of Infectious Disease
[5] Military Medical Academy-Sofia,undefined
[6] PMSI Clinical Hospital of Infectious Diseases “Toma Ciorba”,undefined
[7] Section 3,undefined
[8] Bulevardul Ştefan Cel Mare şi Sfânt,undefined
[9] Nr 163,undefined
[10] PMSI Clinical Hospital of Infectious Diseases “Toma Ciorba”,undefined
[11] Section 4,undefined
[12] Bulevardul Ştefan Cel Mare şi Sfânt,undefined
[13] nr 163,undefined
[14] Immunic AG,undefined
来源：
Infectious Diseases and Therapy | 2022年 / 11卷
关键词：
COVID-19; Dihydroorotate dehydrogenase inhibitor; Vidofludimus calcium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2159 / 2176
页数：17
相关论文
共 103 条
[1]  
Gordan AC(2021)Interleukin-6 receptor antagonists in critically ill patients with Covid-19 N Engl J Med 384 1491-1502
[2]  
Mouncey PR(2021)Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Lancet 397 1637-1645
[3]  
Al-Beidh F(2020)Efficacy of tocilizumab in patients hospitalized with Covid-19 N Engl J Med 383 2333-2344
[4]  
Stone JH(2022)Molnupiravir for oral treatment of covid-19 in nonhospitalized patients N Engl J Med 386 509-520
[5]  
Frigault MJ(2020)Remdesivir for the treatment of Covid-19—final report N Engl J Med 383 1813-1826
[6]  
Serling-Boyd NJ(2021)Combining antivirals and immunomodulators to fight COVID-19 Trends Immunol 42 31-807
[7]  
Bernal AJ(2021)Combining immunomodulators and antivirals for COVID-19 Lancet Microbe 2 795-6744
[8]  
Gomes da Silva MM(2021)Baricitinib plus remdesivir for hospitalized adults with Covid-19 N Engl J Med 384 2473-739
[9]  
Musungaie DB(1985)Metabolic activation of the nucleoside analog 9-[(2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus Proc Natl Acad Sci USA 82 6739-1777
[10]  
Beigel JH(2011)Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV) Proc Natl Acad Sci USA 108 821-366
12345678910